Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1694

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 7
Chunk 1694
---
 the achievement of pre-established performance targets, market
conditions and internal milestones. The Company does not follow a predetermined schedule for the granting of equity awards; instead,
each grant is considered on a case-by-case basis to align with the Company’s strategic objectives and to ensure the competitiveness
of our compensation packages.

In determining the timing and terms of an equity
award, the Board or the Compensation Committee may consider material nonpublic information to ensure that such grants are made in compliance
with applicable laws and regulations. The Board’s or the Compensation Committee’s procedures to prevent the improper use
of material nonpublic information in connection with the granting of equity awards include oversight by legal counsel and, where appropriate,
delaying the grant of equity awards until the public disclosure of such material nonpublic information.

The Company is committed to maintaining transparency
in its executive compensation practices and to making equity awards in a manner that is not influenced by the timing of the disclosure
of material nonpublic information for the purpose of affecting the value of executive compensation. The Company regularly reviews its
policies and practices related to equity awards to ensure they meet the evolving standards of corporate governance and continue to serve
the best interests of the Company and its shareholders. 

Participation of Employee Directors; New
Directors

Unless separately and specifically approved by
the Compensation Committee in its discretion, none of our employee directors shall be entitled to receive any remuneration for service
as a director (other than expense reimbursement as per prevailing policy).

Director Compensation

As of December 31, 2024

    Name 
    Fees
                                            Earned or Paid in Cash  ($)  
    Stock
                                            Awards  ($)  
    Option
                                            Awards  ($)(1)  
    Non-Equity
                                            Incentive Plan Compensation  ($)  
    All
                                            Other Compensation  ($)  
    Total
                                             ($) 
  
    Charles Allen 
     73,000  
             -  
     912  
             -  
           -  
     73,912 
  
    Cheryl Xu 
     65,000  
     -  
     912  
     -  
     -  
     65,912 
  
    Stephen Toovey 
     70,000  
     -  
     912  
     -  
     -  
     70,912 
  
    Paul Field 
     70